Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis.
Yoshitaka SaitoYoh TakekumaMasaki KobayashiTatsuhiko SakamotoHiroko YamashitaMitsuru SugawaraPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Pegfilgrastim co-administration is an independent risk factor for ≥ G2 and all-grade T-APS, and age younger than 55 years is a risk factor of all-grade T-APS under prophylactic DEX administration.